Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-02 Purchase |
2021-02-04 5:56 pm |
Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner |
130,000 | $15 | $1,950,000 | 17,660,752 (Indirect) |
View |
| 2020-12-11 Purchase |
2020-12-14 5:15 pm |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
7,700 | $6.6572 | $51,261 | 17,700 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-02 4:44 pm |
Evelo Biosciences Inc. | EVLO | Liu Xiaoli Jacqueline Principal Accounting Officer |
3,000 | $5.17 | $15,510 | 0 (Direct) |
View |
| 2020-08-28 Purchase |
2020-09-01 4:13 pm |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
10,000 | $4.4435 | $44,435 | 10,000 (Direct) |
View |
| 2020-06-29 Purchase |
2020-07-01 5:24 pm |
Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
4,666,666 | $3.75 | $17,499,998 | 17,614,323 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-19 Option Award |
2022-01-21 4:53 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:50 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:48 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | Scavo Luca CFO |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:42 pm |
N/A 2032-01-19 |
Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-03 4:23 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,926 | $0 | 76,809 (Direct) |
View |
| 2021-11-30 Exercise |
2021-12-01 4:39 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,926 | $0 | 76,809 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-01 5:22 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,925 | $0 | 76,809 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-01 4:42 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
4,927 | $0 | 76,809 (Direct) |
View |
Ownership |
2021-09-29 4:36 pm |
N/A 2031-09-01 |
Evelo Biosciences Inc. | EVLO | CARRIERE STEPHEN J Principal Accounting Officer |
0 | $0 | 75,000 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 06:59 am |
N/A 2031-09-01 |
Evelo Biosciences Inc. | EVLO | McInnes Iain B. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-09-03 Exercise |
2021-09-03 4:55 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
9,850 | $0 | 76,809 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:25 pm |
N/A N/A |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
59,109 | $0 | 59,109 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 4:18 pm |
N/A 2031-06-14 |
Evelo Biosciences Inc. | EVLO | Plinio Mark D. Chief Commercial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-11 4:07 pm |
N/A 2031-06-07 |
Evelo Biosciences Inc. | EVLO | MELAS KYRIAZI THEO Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-11 4:06 pm |
N/A 2031-06-07 |
Evelo Biosciences Inc. | EVLO | PERRY DAVID P Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-11 4:04 pm |
N/A 2031-06-07 |
Evelo Biosciences Inc. | EVLO | Andres Juan Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-11 4:02 pm |
N/A 2031-06-07 |
Evelo Biosciences Inc. | EVLO | Darzi Lord Ara Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 4:49 pm |
N/A 2031-05-31 |
Evelo Biosciences Inc. | EVLO | Scavo Luca CFO |
304,545 | $0 | 304,545 (Direct) |
View |
| 2021-04-09 Option Award |
2021-04-13 4:56 pm |
N/A 2031-04-08 |
Evelo Biosciences Inc. | EVLO | McHugh Julie Director |
31,380 | $0 | 31,380 (Direct) |
View |
Ownership |
2021-04-13 4:53 pm |
N/A 2030-04-13 |
Evelo Biosciences Inc. | EVLO | McHugh Julie Director |
0 | $0 | 11,768 (Direct) |
View |
| 2021-01-27 Option Award(A) |
2021-02-01 5:07 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Zung Jonathan B. Chief Development Officer |
310,000 | $0 | 310,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:34 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO |
275,000 | $0 | 275,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:33 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Hohneker John Director |
31,380 | $0 | 31,380 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:32 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D |
179,000 | $0 | 179,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:30 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer |
96,500 | $0 | 96,500 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:30 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Liu Xiaoli Jacqueline Principal Accounting Officer |
29,680 | $0 | 29,680 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:29 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Char Daniel General Counsel |
57,000 | $0 | 57,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 5:28 pm |
N/A 2031-01-27 |
Evelo Biosciences Inc. | EVLO | Zung Jonathan B. Chief Development Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2020-10-11 Option Award |
2020-10-14 5:53 pm |
N/A 2030-10-11 |
Evelo Biosciences Inc. | EVLO | Epstein David R Director |
104,138 | $0 | 104,138 (Direct) |
View |
| 2020-07-10 Option Award |
2020-07-14 4:26 pm |
N/A 2030-07-10 |
Evelo Biosciences Inc. | EVLO | Liu Xiaoli Jacqueline Principal Accounting Officer |
30,000 | $0 | 30,000 (Direct) |
View |